Dans les interstices entre le sommeil et l'éveil, un chercheur français a passé quatre décennies à chercher ce qui se brise. Emmanuel Mignot, psychiatre et pharmacologue installé à Stanford depuis la fin des années 1980, reçoit le prix Lasker pour ses travaux sur la narcolepsie — une maladie rare qui touche environ une personne sur deux mille et que la médecine a longtemps négligée. Partagé avec le chercheur japonais Masashi Yanagisawa, ce prix consacre non seulement une carrière, mais signale que la biologie du sommeil est enfin reconnue comme une frontière légitime de la science.
Le Monde.fr
· Sep 10, 2026
· health
· 1 min read
High
Sourcing: Verified
French researcher Emmanuel Mignot wins Lasker Award for narcolepsy breakthrough
Narcolepsy affects approximately one in 2,000 people, causing significant disability and impacting quality of life for patients worldwide.
◉
Education
1711 related articles
DOJ Investigates Duke Law's Race-Based Admissions Practices Post-SCOTU…
Fox News · 100% match
Brown professor exposes 40-student AI cheating scandal, criticizes uni…
Fox News · 99% match
Low CLAT Score? Here's Your Roadmap to Law School Through Alternate Ex…
The Indian Express · 99% match
Three Nature Papers Validate Organoid Models as Next-Generation Precis…
Oncodaily · 90% match
Diet Quality Trumps Processing Level in New Health Study
Genetic Literacy Project · 90% match
Related Coverage
EurekAlert! · Sep 10
Molecular Antennae Boost Light-Activated Switches to Record Sensitivity
Researchers at Tohoku University developed molecular antennae that dramatically increase visible-light sensitivity in ph…
News-Medical · Sep 10 Harvard researchers map path to lifetime brain-wide neural recording technologyHarvard researchers published a technological roadmap for implantable microelectronics enabling brain-wide neural record…
Tribune Online · Sep 10 Why the UN's map correction matters: Decolonising perception, starting with Africa's true sizeAn opinion piece argues that the UN's adoption of the Equal Earth map over the Mercator projection represents a crucial …
Fox News · Sep 10 Student protest planned at Charlie Kirk memorial on UVU campusTurning Point USA will hold a memorial for founder Charlie Kirk at Utah Valley University on the anniversary of his deat…
Bias & Framing
⚖
Article presents a straightforward, celebratory account of a French researcher's scientific achievement with minimal apparent bias, though framing emphasizes personal charm over research substance.
Bias Direction
center
Confidence
MED
Human-interest narrative combined with achievement celebration. The opening anecdote about the researcher's dog and phone scrolling creates an intimate, relatable tone that personalizes the scientist rather than focusing primarily on the scientific breakthrough itself.
instinctively dove into
highly debilitating
prestigious Lasker Award
Voices of narcolepsy patients or patient advocacy groups discussing the impact of this research
Perspective from other competing researchers or institutions
Scientific critique or context about the significance of the specific breakthrough
Details about the research methodology or findings themselves
Geopolitical Impact
🌎
French researcher's scientific achievement in narcolepsy research represents continued Franco-Japanese scientific collaboration and US-based research excellence, with minimal geopolitical implications.
Escalation Risk
low
Confidence
HIGH
France
Japan
United States
Demonstrates sustained scientific soft power of France and Japan through prestigious international awards; reinforces US position as hub for global research talent and institutions. Franco-Japanese collaboration in biomedical research strengthens trilateral scientific ties.
Reflects post-WWII pattern of France and Japan leveraging scientific excellence as soft power while contributing to US-led research ecosystem, similar to earlier CERN and international research collaborations.
Economic Lens
📈
French researcher's Lasker Award for narcolepsy breakthrough signals growing biomedical innovation and potential future pharmaceutical market opportunities in sleep disorder treatments.
Market Signal
bullish
Confidence
MED
Pharmaceutical and biotechnology
Healthcare and medical research
Medical devices and diagnostics
Higher education and research institutions
Consumers with narcolepsy and related sleep disorders may benefit from improved treatments and therapies resulting from decades of research, potentially reducing healthcare costs and improving quality of life for affected populations.
Recognition of breakthrough research may encourage increased government funding for sleep disorder research, influence pharmaceutical R&D priorities, and potentially accelerate regulatory pathways for narcolepsy treatments through FDA and EMA approval processes.